To validate our hypothesis that Parkin is epigenetically regulated, we have further shown that the treatment of 5′-azacytidine, a methyltransferase inhibitor restores Parkin mRNA expression in different breast cancer cell lines. The gene discussed is PRKN; the disease is breast carcinoma.